mAbDx Granted Approval for Development of Monoclonal Antibodies

Mon 10 October 2011

mAbDx granted IACUC approval for the development of monoclonal antibodies and immunoassays to identify and study mitochondrial DAMPs. Project title:  “Defining the contribution of mitochondrial damage-associated-molecular patterns (mtDAMPs) to the systemic inflammatory response syndrome (SIRS) after tissue injury”.